PE20120909A1 - Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma - Google Patents

Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma

Info

Publication number
PE20120909A1
PE20120909A1 PE2011001988A PE2011001988A PE20120909A1 PE 20120909 A1 PE20120909 A1 PE 20120909A1 PE 2011001988 A PE2011001988 A PE 2011001988A PE 2011001988 A PE2011001988 A PE 2011001988A PE 20120909 A1 PE20120909 A1 PE 20120909A1
Authority
PE
Peru
Prior art keywords
mycoplasma hyopneumoniae
strain
sensitive
temperature
same
Prior art date
Application number
PE2011001988A
Other languages
English (en)
Spanish (es)
Inventor
Rima Youil
El-Osta Youssef Abs
Glenn Browning
Phillip Markham
Original Assignee
Bioproperties Pty Ltd
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009902255A external-priority patent/AU2009902255A0/en
Application filed by Bioproperties Pty Ltd, Univ Melbourne filed Critical Bioproperties Pty Ltd
Publication of PE20120909A1 publication Critical patent/PE20120909A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
PE2011001988A 2009-05-19 2010-05-19 Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma PE20120909A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2009902255A AU2009902255A0 (en) 2009-05-19 Bacterial strain, vaccine and uses thereof

Publications (1)

Publication Number Publication Date
PE20120909A1 true PE20120909A1 (es) 2012-08-19

Family

ID=43125658

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011001988A PE20120909A1 (es) 2009-05-19 2010-05-19 Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma

Country Status (17)

Country Link
US (1) US8524252B2 (cg-RX-API-DMAC7.html)
EP (1) EP2453913B1 (cg-RX-API-DMAC7.html)
JP (1) JP5744852B2 (cg-RX-API-DMAC7.html)
KR (1) KR101734590B1 (cg-RX-API-DMAC7.html)
CN (1) CN102458462B (cg-RX-API-DMAC7.html)
AU (1) AU2010251761B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1010679B1 (cg-RX-API-DMAC7.html)
CA (1) CA2762587C (cg-RX-API-DMAC7.html)
CL (1) CL2011002923A1 (cg-RX-API-DMAC7.html)
DK (1) DK2453913T3 (cg-RX-API-DMAC7.html)
EA (1) EA021102B1 (cg-RX-API-DMAC7.html)
ES (1) ES2579935T3 (cg-RX-API-DMAC7.html)
MX (1) MX2011012362A (cg-RX-API-DMAC7.html)
NZ (1) NZ596722A (cg-RX-API-DMAC7.html)
PE (1) PE20120909A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010132932A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201109185B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012013409A (es) * 2010-05-19 2013-03-07 Bioproperties Pty Ltd Metodos relacionados a un micoplasma atenuado.
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体,转化的猪肺炎支原体菌株及其用途
EP2684959A1 (en) 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
AU2013370982C9 (en) 2012-12-28 2019-01-24 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
EP2913947B1 (en) * 2014-02-27 2019-11-27 ADVA Optical Networking SE Passive optical network and optical line terminal
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
AU2016380864B2 (en) 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
US10071149B2 (en) 2016-05-03 2018-09-11 Brigham Young University Temperature sensitive multivalent Bordetella avium vaccines
CN113278575B (zh) * 2021-07-13 2021-12-31 南华大学 一种肺炎支原体减毒突变株及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
CN1100871C (zh) * 1999-06-25 2003-02-05 江苏省农业科学院畜牧兽医研究所 猪肺炎支原体克隆致弱株
US6673567B2 (en) * 2000-03-23 2004-01-06 E. I. Du Pont De Nemours And Company Method of determination of gene function
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
MXPA03011924A (es) * 2001-07-02 2004-03-26 Pfizer Prod Inc Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
JP2009528361A (ja) * 2006-03-03 2009-08-06 メリアル リミテッド マイコプラズマ・ハイオニューモニエワクチン
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
DK2475384T3 (en) * 2009-09-10 2016-10-24 Merial Inc NEW VACCINE FORMULATIONS COMPREHENSIVE saponin-CONTAINING ADJUVANTS
US9324223B2 (en) 2012-06-08 2016-04-26 3M Innovative Properties Company Electronic monitoring home unit and installation methods

Also Published As

Publication number Publication date
KR20120016282A (ko) 2012-02-23
EP2453913B1 (en) 2016-06-22
EP2453913A1 (en) 2012-05-23
EP2453913A4 (en) 2013-10-30
CN102458462B (zh) 2014-03-19
US20120135040A1 (en) 2012-05-31
WO2010132932A1 (en) 2010-11-25
AU2010251761A1 (en) 2011-12-22
CN102458462A (zh) 2012-05-16
EA201190311A1 (ru) 2012-06-29
DK2453913T3 (en) 2016-07-25
JP5744852B2 (ja) 2015-07-08
ZA201109185B (en) 2012-09-26
NZ596722A (en) 2013-08-30
BRPI1010679B1 (pt) 2020-09-24
CL2011002923A1 (es) 2012-08-31
MX2011012362A (es) 2012-04-19
EA021102B1 (ru) 2015-04-30
CA2762587C (en) 2017-11-28
CA2762587A1 (en) 2010-11-25
JP2012527218A (ja) 2012-11-08
KR101734590B1 (ko) 2017-05-11
ES2579935T3 (es) 2016-08-17
AU2010251761B2 (en) 2014-10-09
BRPI1010679A2 (pt) 2017-07-18
US8524252B2 (en) 2013-09-03

Similar Documents

Publication Publication Date Title
Douzi et al. Per-cooling (Using cooling systems during physical exercise) enhances physical and cognitive performances in hot environments. a narrative review
BR112016006589A2 (pt) composição, e composição de vacina
BR112013018686A2 (pt) sistemas e métodos para uso médico de captura e imageamento de movimentação
CL2015001986A1 (es) (divisional solicitud 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos
BRPI0909352A2 (pt) dispositivo terapêutico e que pode ser colocado em contato com um paciente para terapeuticamento resfriar o paciente, sistema para regularizar terapeuticamente a temperatura do corpo de um paciente, método terapêutico para regularizar a temperatura do corpo de um paciente método para terapeuticamente resfriar a temperatura do corpo de um paciente, invólucro, e, envoltório.
BR112012022797A2 (pt) composição farmacêutica resistente a álcool, e, método para tratar uma doença com uma formulação de agente ativo resistente a álcool
BR112013031707A2 (pt) fraldas descartáveis
CO6420388A2 (es) Formulacion que comprende particulas de avermectina cubiertas con un agente fotoprotector
BR112014013786A8 (pt) método para ventilação de um indivíduo, método para rapidamente ventilar um indivíduo que apresenta desconforto respiratório, e, dispositivo para ventilação de um indivíduo através de uma ou mais passagens do corpo
CL2011002923A1 (es) Cepa de mycoplasma hyopneumoniae; composicion de vacuna que la comprende; metodo de preparacion; y su uso para prevenir una enfermedad causada por mycoplasma hyopneumoniae en un animal porcino.
UY32570A (es) Vacuna viva modificada de mycoplasma bovis mejorada
HK1212249A1 (en) Bioconjugates comprising modified antigens and uses thereof
BR112014028248A2 (pt) ligação de plugue para linhas de fluido e parte de retenção para uma ligação de plugue desse tipo
BR112015018259A2 (pt) Redução de resposta pró-inflamatória
UY32208A (es) Uso de antigeno de mycoplasma bovis
BR112013030752A2 (pt) composição de resfriamento e artigo absorvente que compreende a mesma
CL2015001803A1 (es) Composición inmunogénica que comprende cepas del virus del oeste del nilo muerto o inactivado o cualquier antígeno del mismo; y método para disminuir síntomas clínicos asociados a infección por dicho virus en animales (div. sol. n° 445-11)
BR112015024402A2 (pt) suporte de paciente
BR112012020665A2 (pt) artigo depilatório
Brotons et al. Cost of hospitalizing children with invasive pneumococcal pneumonia
BR112013003064A2 (pt) agente profilático ou terapêutico para a esteato-hepatite não alcoólica
Kim et al. A study on occupational satisfaction and stress of visiting nurses at district health centers in Chungnam Province
BRPI0602397C1 (pt) composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições
WO2014030052A3 (en) Compositions comprising an antibody and camostat mesylate (cm)
Deresinski et al. Immunotherapies for Staphylococcus aureus: current challenges and future prospects

Legal Events

Date Code Title Description
FC Refusal